{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:01:12Z","timestamp":1787065272013,"version":"build-2736575974"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/00806"],"award-info":[{"award-number":["PI23\/00806"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014849","name":"Valencia Department of Education Culture and Sport","doi-asserted-by":"publisher","award":["CIAPOT\/2021\/13"],"award-info":[{"award-number":["CIAPOT\/2021\/13"]}],"id":[{"id":"10.13039\/501100014849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118942","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:34:21Z","timestamp":1767681261000},"page":"118942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Descriptive overview of gene variants potentially affecting female infertility treatments: A systematic review"],"prefix":"10.1016","volume":"194","author":[{"given":"Asunta","family":"Martinez-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garcia-Acero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Sebastian-Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-7545","authenticated-orcid":false,"given":"Patricia","family":"Diaz-Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib1","first-page":"175","article-title":"Early Life Circumstances and Their Impact on Menarche and Menopause","volume":"5","author":"Mishra","year":"2009","journal-title":"Women\u2019s. Health"},{"issue":"9744","key":"10.1016\/j.biopha.2025.118942_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(10)60355-8","article-title":"Primary ovarian insufficiency","volume":"376","author":"De Vos","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib3","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.3390\/ijms24065682","article-title":"Endocrine Disruptor Compounds in Environment: Focus on Women\u2019s Reproductive Health and Endometriosis","volume":"24","author":"Interdonato","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"9837","key":"10.1016\/j.biopha.2025.118942_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(12)60827-7","article-title":"The economic consequences of reproductive health and family planning","volume":"380","author":"Canning","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib6","first-page":"9","article-title":"A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care","volume":"24","author":"Chenchula","year":"2024","journal-title":"Pharm. J. abril De."},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jpag.2025.01.111","article-title":"78. Navigating the Trial-and-Error Landscape of Contraceptive Prescribing: A Call for Personalized Contraceptive Care","volume":"38","author":"Monestime","year":"2025","journal-title":"J. Pedia Adolesc. Gynecol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/wsbm.1302","article-title":"Parsing interindividual drug variability: an emerging role for systems pharmacology","volume":"7","author":"Turner","year":"2015","journal-title":"WIREs Syst. Biol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2020.151221","article-title":"Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care","volume":"44","author":"Pinheiro","year":"2020","journal-title":"Semin Perinatol."},{"key":"10.1016\/j.biopha.2025.118942_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/PPA.S103156","article-title":"Weight-based dosing in medication use: what should we know?","author":"Zhou","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.rbmo.2015.05.001","article-title":"Genetic variants associated with female reproductive ageing - potential markers for assessing ovarian function and ovarian stimulation outcome","volume":"31","author":"Laisk-Podar","year":"2015","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13073-017-0502-5","article-title":"Genetic variation in human drug-related genes","volume":"9","author":"Sch\u00e4rfe","year":"2017","journal-title":"Genome Med"},{"issue":"9","key":"10.1016\/j.biopha.2025.118942_bib13","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/bcp.13999","article-title":"Implementation and obstacles of pharmacogenetics in clinical practice: An international survey","volume":"85","author":"Abou Diwan","year":"2019","journal-title":"Br. J. Clin. Pharm."},{"issue":"9242","key":"10.1016\/j.biopha.2025.118942_bib14","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0140-6736(00)03167-6","article-title":"Pharmacogenetics and adverse drug reactions","volume":"356","author":"Meyer","year":"2000","journal-title":"Lancet Lond. Engl."},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib15","first-page":"395","article-title":"Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?","volume":"17","author":"Verbelen","year":"2017","journal-title":"Pharm. J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12884-017-1290-z","article-title":"Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research","volume":"17","author":"Daud","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.biopha.2025.118942_bib17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2025.118942_bib18","unstructured":"Wells G., Shea B., O\u2019Connell D., Robertson J., Peterson J., Welch V., et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta- Analysis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ogrm.2023.01.006","article-title":"Principles of controlled ovarian stimulation for assisted reproduction","volume":"33","author":"Palinska-Rudzka","year":"2023","journal-title":"Obstet. Gynaecol. Reprod. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib20","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.fertnstert.2006.11.165","article-title":"Methylenetetrahydrofolate reductase (MTHFR) is associated with ovarian follicular activity","volume":"88","author":"Rosen","year":"2007","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ogrm.2023.01.006","article-title":"Principles of controlled ovarian stimulation for assisted reproduction","volume":"33","author":"Palinska-Rudzka","year":"2023","journal-title":"Obstet. Gynaecol. Reprod. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ymgme.2011.04.005","article-title":"Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: A meta-analysis","volume":"103","author":"Yao","year":"2011","journal-title":"Mol. Genet Metab. 1 De. Agosto De."},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0015-0282(03)01115-4","article-title":"Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility","volume":"80","author":"Laven","year":"2003","journal-title":"Fertil. Steril."},{"issue":"9","key":"10.1016\/j.biopha.2025.118942_bib24","first-page":"3365","article-title":"Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype","volume":"85","author":"Perez Mayorga","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10815-005-9015-z","article-title":"FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF\/ICSI-ET programs","volume":"23","author":"Loutradis","year":"2006","journal-title":"J. Assist Reprod. Genet"},{"issue":"8","key":"10.1016\/j.biopha.2025.118942_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10038-006-0005-5","article-title":"Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET","volume":"51","author":"Jun","year":"2006","journal-title":"J. Hum. Genet"},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.fertnstert.2015.01.002","article-title":"Follicle-stimulating hormone receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (World Health Organization class 2) anovulatory subfertility","volume":"103","author":"Valkenburg","year":"2015","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.biopha.2025.118942_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078138","article-title":"Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in Chinese women: a prospective clinical study","volume":"8","author":"Yan","year":"2013","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.biopha.2025.118942_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.fpc.0000167330.92786.5e","article-title":"Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation","volume":"15","author":"Behre","year":"2005","journal-title":"Pharm. Genom."},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038700","article-title":"Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI","volume":"7","author":"Boudjenah","year":"2012","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0015-0282(03)00795-7","article-title":"Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone","volume":"80","author":"de Castro","year":"2003","journal-title":"Fertil. Steril. septiembre De."},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0974-1208.86089","article-title":"Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation","volume":"4","author":"Sheikhha","year":"2011","journal-title":"J. Hum. Reprod. Sci. mayo De."},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/FPC.0b013e32835fe813","article-title":"Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response","volume":"23","author":"Lledo","year":"2013","journal-title":"Pharm. Genom."},{"issue":"8","key":"10.1016\/j.biopha.2025.118942_bib34","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/1933719116630419","article-title":"In Estimated Good Prognosis Patients Could Unexpected \u00abHyporesponse\u00bb to Controlled Ovarian Stimulation be Related to Genetic Polymorphisms of FSH Receptor?","volume":"23","author":"Alviggi","year":"2016","journal-title":"Reprod. Sci. Thousand Oaks Calif."},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2021.100499","article-title":"Association between FSHR and ESR1 gene variants and ovarian response to gonadotropin in Egyptian women undergoing ICSI treatment","volume":"21","author":"Ahmed","year":"2021","journal-title":"Reprod. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib36","first-page":"285","article-title":"Human controlled ovarian hyperstimulation outcome is a polygenic trait","volume":"14","author":"de Castro","year":"2004","journal-title":"Pharm. mayo De."},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib37","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/humrep\/deab068","article-title":"The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia","volume":"36","author":"Polyzos","year":"2021","journal-title":"Hum. Reprod. Oxf. Engl."},{"issue":"12","key":"10.1016\/j.biopha.2025.118942_bib38","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1210\/jc.2004-1044","article-title":"Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism","volume":"89","author":"Daelemans","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib39","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1159\/000366356","article-title":"Ala307Thr and Asn680Ser polymorphisms of FSHR gene in human reproduction outcomes","volume":"34","author":"Trevisan","year":"2014","journal-title":"Cell Physiol. Biochem Int J. Exp. Cell Physiol. Biochem Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1472-6483(10)60660-8","article-title":"FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF","volume":"13","author":"Klinkert","year":"2006","journal-title":"Reprod. Biomed. Online"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2174\/138920112799361891","article-title":"ESR1, ESR2 and FSH receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders","volume":"13","author":"Anagnostou","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/FPC.0000000000000374","article-title":"The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation","volume":"29","author":"Nenonen","year":"2019","journal-title":"Pharm. Genom."},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.rbmo.2011.02.015","article-title":"A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation","volume":"23","author":"Hanevik","year":"2011","journal-title":"Reprod. Biomed. Online"},{"issue":"12","key":"10.1016\/j.biopha.2025.118942_bib44","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s10815-017-1013-4","article-title":"The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure","volume":"34","author":"Motawi","year":"2017","journal-title":"J. Assist Reprod. Genet"},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1472-6483(10)60127-7","article-title":"Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism","volume":"18","author":"Achrekar","year":"2009","journal-title":"Reprod. Biomed. Online"},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib46","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.fertnstert.2007.11.093","article-title":"Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women","volume":"91","author":"Achrekar","year":"2009","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.rbmo.2016.06.001","article-title":"Association of a promoter polymorphism in FSHR with ovarian reserve and response to ovarian stimulation in women undergoing assisted reproductive treatment","volume":"33","author":"Tohlob","year":"2016","journal-title":"Reprod. Biomed. Online"},{"issue":"10","key":"10.1016\/j.biopha.2025.118942_bib48","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/molehr\/8.10.893","article-title":"Genetic and functional analyses of polymorphisms in the human FSH receptor gene","volume":"8","author":"Sudo","year":"2002","journal-title":"Mol. Hum. Reprod. Oct. De."},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10815-008-9279-1","article-title":"A distribution of two SNPs in exon 10 of the FSHR gene among the women with a diminished ovarian reserve in Ukraine","volume":"26","author":"Livshyts","year":"2009","journal-title":"J. Assist Reprod. Genet"},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.rbmo.2013.07.007","article-title":"Association of allelic combinations of FSHR gene polymorphisms with ovarian response","volume":"27","author":"Desai","year":"2013","journal-title":"Reprod. Biomed. Online"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.rbmo.2021.06.016","article-title":"Associations of FSHR and LHCGR gene variants with ovarian reserve and clinical pregnancy rates","volume":"43","author":"Guo","year":"2021","journal-title":"Reprod. Biomed. Online"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib52","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/humrep\/dev342","article-title":"Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization","volume":"31","author":"Lindgren","year":"2016","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib53","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.fertnstert.2022.06.011","article-title":"Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology","volume":"118","author":"Pirtea","year":"2022","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib54","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/genes14061269","article-title":"Genetic Variants of Gonadotropins and Their Receptors Could Influence Controlled Ovarian Stimulation: IVF Data from a Prospective Multicenter Study","volume":"14","author":"Alviggi","year":"2023","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib55","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s10815-025-03471-z","article-title":"Pharmacogenetic analysis using artificial intelligence (AI) to identify polymorphisms associated with sub-optimal ovarian response and hyper-response","volume":"42","author":"Ortiz","year":"2025","journal-title":"J. Assist Reprod. Genet"},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10815-018-1318-y","article-title":"Gonadotropin receptor variants are linked to cumulative live birth rate after in vitro fertilization","volume":"36","author":"Lindgren","year":"2019","journal-title":"J. Assist Reprod. Genet"},{"issue":"11","key":"10.1016\/j.biopha.2025.118942_bib57","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1007\/s43032-024-01700-x","article-title":"The Additive Effect of Combinations of FSH Receptor Gene Variants in Ovarian Response to Stimulation","volume":"31","author":"Neves","year":"2024","journal-title":"Reprod. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118942_bib58","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1210\/jc.2011-1064","article-title":"Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells","volume":"96","author":"Desai","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.biopha.2025.118942_bib59","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/humrep\/12.7.1430","article-title":"Oestrogen receptor gene polymorphisms and ovarian stimulation for in-vitro fertilization","volume":"12","author":"Georgiou","year":"1997","journal-title":"Hum. Reprod."},{"issue":"9","key":"10.1016\/j.biopha.2025.118942_bib60","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/molehr\/5.9.797","article-title":"Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF","volume":"5","author":"Sundarrajan","year":"1999","journal-title":"Mol. Hum. Reprod."},{"issue":"8","key":"10.1016\/j.biopha.2025.118942_bib61","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/molehr\/gam035","article-title":"Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization","volume":"13","author":"Altm\u00e4e","year":"2007","journal-title":"Mol. Hum. Reprod."},{"issue":"9-10","key":"10.1016\/j.biopha.2025.118942_bib62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10815-009-9354-2","article-title":"Evaluation of in vitro fertilization parameters and estrogen receptor alpha gene polymorphisms for women with unexplained infertility","volume":"26","author":"Ayvaz","year":"2009","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.biopha.2025.118942_bib63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13048-014-0114-2","article-title":"ESR1 and ESR2 gene polymorphisms are associated with human reproduction outcomes in Brazilian women","volume":"7","author":"de Mattos","year":"2014","journal-title":"J. Ovarian Res"},{"issue":"9","key":"10.1016\/j.biopha.2025.118942_bib64","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/FPC.0000000000000386","article-title":"The relevance of the individual screening for genetic variants in predicting ovarian response","volume":"29","author":"Lled\u00f3","year":"2019","journal-title":"Pharm. Genom."},{"issue":"11","key":"10.1016\/j.biopha.2025.118942_bib65","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10815-012-9849-0","article-title":"The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism","volume":"29","author":"Lazaros","year":"2012","journal-title":"J. Assist Reprod. Genet"},{"issue":"11","key":"10.1016\/j.biopha.2025.118942_bib66","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10815-013-0134-7","article-title":"Analyzing the possible involvement of anti-M\u00fcllerian hormone and anti-M\u00fcllerian hormone receptor II single nucleotide polymorphism in infertility","volume":"31","author":"Yoshida","year":"2014","journal-title":"J. Assist Reprod. Genet"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10815-014-0403-0","article-title":"Single nucleotide polymorphisms in the Anti-M\u00fcllerian hormone (AMH Ile(49)Ser) and Anti-M\u00fcllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology","volume":"32","author":"Karagiorga","year":"2015","journal-title":"J. Assist Reprod. Genet"},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib69","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1159\/000373961","article-title":"AMH and AMHR2 polymorphisms and AMH serum level can predict assisted reproduction outcomes: a cross-sectional study","volume":"35","author":"Peluso","year":"2015","journal-title":"Cell Physiol. Biochem Int J. Exp. Cell Physiol. Biochem Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2025.118942_bib70","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10815-016-0711-7","article-title":"AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation","volume":"33","author":"Cerra","year":"2016","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.biopha.2025.118942_bib71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejogrb.2018.01.025","article-title":"Role of Lh polymorphisms and r-hLh supplementation in GnRh agonist treated ART cycles: A cross sectional study","volume":"222","author":"G A","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.biopha.2025.118942_bib72","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7827-11-71","article-title":"Association between the luteinizing hormone\/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation","volume":"11","author":"O\u2019Brien","year":"2013","journal-title":"Reprod. Biol. Endocrinol. RBE"},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib73","first-page":"447","article-title":"GDF9 polymorphisms: influence on ovarian response in women undergoing controlled ovarian hyperstimulation","volume":"24","author":"Bilibio","year":"2020","journal-title":"JBRA Assist Reprod."},{"issue":"7","key":"10.1016\/j.biopha.2025.118942_bib74","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.fpc.0000215073.44589.96","article-title":"Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS)","volume":"16","author":"Mor\u00f3n","year":"2006","journal-title":"Pharm. Genom."},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib75","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.fertnstert.2010.03.070","article-title":"G546A polymorphism of growth differentiation factor-9 contributes to the poor outcome of ovarian stimulation in women with diminished ovarian reserve","volume":"94","author":"Wang","year":"2010","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib76","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.3892\/mmr.2016.5060","article-title":"Effect of growth differentiation factor\u20119 C447T and G546A polymorphisms on the outcomes of in vitro fertilization","volume":"13","author":"Serdy\u0144ska\u2011Szuster","year":"2016","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.biopha.2025.118942_bib77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejogrb.2018.06.001","article-title":"A pharmacogenetic approach to improve low ovarian response: The role of CAG repeats length in the androgen receptor gene","volume":"227","author":"Lledo","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.rbmo.2014.09.016","article-title":"Ovarian response is affected by a specific histidine-rich glycoprotein polymorphism: a preliminary study","volume":"30","author":"Nordqvist","year":"2015","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.biopha.2025.118942_bib79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7827-11-51","article-title":"A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology","volume":"11","author":"Alviggi","year":"2013","journal-title":"Reprod. Biol. Endocrinol. RBE"},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib80","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S1472-6483(11)60011-4","article-title":"Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism","volume":"22","author":"Alviggi","year":"2011","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/09513590.2010.493961","article-title":"Association of serum and follicular fluid SHBG levels and SHBG (TAAAA)n polymorphism with follicle size in women undergoing ovarian stimulation","volume":"27","author":"Hatzi","year":"2011","journal-title":"Gynecol. Endocrinol. J. Int Soc. Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib82","first-page":"428","article-title":"Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study","volume":"27","author":"Rosa","year":"2023","journal-title":"JBRA Assist Reprod."},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib83","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.rbmo.2010.12.006","article-title":"Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF","volume":"22","author":"van Disseldorp","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.biopha.2025.118942_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2024.07.054","article-title":"Calcium versus cabergoline for prevention of ovarian hyperstimulation syndrome: A systematic review and meta-analysis","volume":"301","author":"Baradwan","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118942_bib85","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/jpm14090915","article-title":"Ovarian Hyperstimulation Syndrome (OHSS): A Narrative Review and Legal Implications","volume":"14","author":"Gullo","year":"2024","journal-title":"J. Pers. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib86","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0015-0282(01)03218-6","article-title":"Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome","volume":"77","author":"Dulitzky","year":"2002","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib87","doi-asserted-by":"crossref","first-page":"2352142","DOI":"10.1080\/09513590.2024.2352142","article-title":"Effect of estrogen exposure on pregnancy outcomes in artificial frozen-thawed embryo transfer cycles","volume":"40","author":"Wei","year":"2024","journal-title":"Gynecol. Endocrinol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118942_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102274","article-title":"Utilizing FMR1 Gene Mutations as Predictors of Treatment Success in Human In Vitro Fertilization","volume":"9","author":"Kushnir","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib89","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10815-014-0403-0","article-title":"Single nucleotide polymorphisms in the Anti-M\u00fcllerian hormone (AMH Ile49Ser) and Anti-M\u00fcllerian hormone type II receptor (AMHRII \u2212482 A>G) as genetic markers in assisted reproduction technology","volume":"32","author":"Karagiorga","year":"2015","journal-title":"J. Assist Reprod. Genet"},{"issue":"4","key":"10.1016\/j.biopha.2025.118942_bib90","first-page":"251","article-title":"Effects of the common 677C>T mutation of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene on ovarian responsiveness to recombinant follicle-stimulating hormone","volume":"55","author":"Thaler","year":"2006","journal-title":"Am. J. Reprod. Immunol. N. Y N. 1989"},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib91","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.rbmo.2014.02.005","article-title":"MTHFR polymorphisms C677T and A1298C and associations with IVF outcomes in Brazilian women","volume":"28","author":"D\u2019Elia","year":"2014","journal-title":"Reprod. Biomed. Online"},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib92","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.fertnstert.2010.11.022","article-title":"Ala16Val SOD2 polymorphism is associated with higher pregnancy rates in in vitro fertilization cycles","volume":"95","author":"Ruiz-Sanz","year":"2011","journal-title":"Fertil. Steril."},{"issue":"7","key":"10.1016\/j.biopha.2025.118942_bib93","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1080\/01443615.2020.1821619","article-title":"The effects of luteinising hormone gene polymorphism on the outcomes of in vitro fertilisation and embryo transfer","volume":"41","author":"Ku","year":"2021","journal-title":"J. Obstet. Gynaecol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib94","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.rbmo.2011.03.002","article-title":"Folate-metabolizing gene variants and pregnancy outcome of IVF","volume":"22","author":"Laanpere","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.biopha.2025.118942_bib95","series-title":"En: StatPearls [Internet]","article-title":"Polycystic Ovarian Syndrome","author":"Shukla","year":"2025"},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib96","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3109\/09513590.2013.774359","article-title":"CYP19 gene variants affect the assisted reproduction outcome of women with polycystic ovary syndrome","volume":"29","author":"Lazaros","year":"2013","journal-title":"Gynecol. Endocrinol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118942_bib97","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10815-011-9619-4","article-title":"FSH-receptor Ala307Thr polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women","volume":"28","author":"Dolfin","year":"2011","journal-title":"J. Assist Reprod. Genet"},{"issue":"8","key":"10.1016\/j.biopha.2025.118942_bib98","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/humrep\/dep114","article-title":"Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome","volume":"24","author":"Overbeek","year":"2009","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib99","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jc.2007-1736","article-title":"Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene","volume":"93","author":"Legro","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib100","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/humrep\/deh747","article-title":"The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome","volume":"20","author":"Ertunc","year":"2005","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.biopha.2025.118942_bib101","doi-asserted-by":"crossref","first-page":"E204","DOI":"10.1210\/jc.2010-0145","article-title":"Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome","volume":"95","author":"Gambineri","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib102","first-page":"597","article-title":"Pharmacogenetics of inflammatory bowel disease \u2606","volume":"18","author":"Mascheretti","year":"2004","journal-title":"Best. Pr. Res Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib103","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1389200215666140130124910","article-title":"Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process","volume":"15","author":"Caudle","year":"2014","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2025.118942_bib104","doi-asserted-by":"crossref","first-page":"1189976","DOI":"10.3389\/fphar.2023.1189976","article-title":"Pharmacogenomics in practice: a review and implementation guide","volume":"14","author":"Kabbani","year":"2023","journal-title":"Front Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2025.118942_bib105","first-page":"1300","article-title":"Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review","volume":"27","author":"Mirza","year":"2024","journal-title":"Value Health J. Int Soc. Pharm. Outcomes Res"},{"key":"10.1016\/j.biopha.2025.118942_bib106","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920974118","article-title":"Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial","volume":"12","author":"Reizine","year":"2020","journal-title":"Ther. Adv. Med Oncol."},{"key":"10.1016\/j.biopha.2025.118942_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105009","article-title":"Clinical implementation of preemptive pharmacogenomics in psychiatry","volume":"101","author":"Skokou","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.biopha.2025.118942_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105009","article-title":"Clinical implementation of preemptive pharmacogenomics in psychiatry","volume":"101","author":"Skokou","year":"2024","journal-title":"eBioMedicine"},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib109","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/bcp.14407","article-title":"Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response","volume":"87","author":"Carr","year":"2021","journal-title":"Br. J. Clin. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2025.118942_bib110","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S1470-2045(18)30686-7","article-title":"DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis","volume":"19","author":"Henricks","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2025.118942_bib111","series-title":"Omics for Personalized Medicine [Internet]","article-title":"Pharmacogenomics and Personalized Medicine in Infertility","author":"Majumdar","year":"2013"},{"issue":"3","key":"10.1016\/j.biopha.2025.118942_bib112","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2019.11.025","article-title":"Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","year":"2020","journal-title":"Fertil. Steril."},{"issue":"9","key":"10.1016\/j.biopha.2025.118942_bib113","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1111\/jocn.17195","article-title":"Infertility psychological distress in women undergoing assisted reproductive treatment: A grounded theory study","volume":"33","author":"Jiang","year":"2024","journal-title":"J. Clin. Nurs."},{"key":"10.1016\/j.biopha.2025.118942_bib114","doi-asserted-by":"crossref","first-page":"1576090","DOI":"10.3389\/fendo.2025.1576090","article-title":"FSH receptor N680S genotype-guided gonadotropin choice increases cumulative pregnancy and live birth rates after in vitro fertilization","volume":"16","author":"Hjelm\u00e9r","year":"2025","journal-title":"Front Endocrinol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118942_bib115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1177\/1933719118765970","article-title":"Pharmacogenomics in IVF: A New Era in the Concept of Personalized Medicine","volume":"26","author":"Kalinderi","year":"2019","journal-title":"Reprod. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib116","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2217\/pgs.14.49","article-title":"Pharmacogenetics of Ovarian Response","volume":"15","author":"Lledo","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.biopha.2025.118942_bib117","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fendo.2019.00398","article-title":"Pharmacogenetics of FSH Action in the Female","volume":"10","author":"Conforti","year":"2019","journal-title":"Front Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118942_bib118","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1472-6483(10)61167-4","article-title":"Pharmacogenetics in ovarian stimulation \u2013 current concepts and future options","volume":"11","author":"Greb","year":"2005","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.biopha.2025.118942_bib119","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fendo.2019.00398","article-title":"Pharmacogenetics of FSH Action in the Female","volume":"10","author":"Conforti","year":"2019","journal-title":"Front Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/jcm10020170","article-title":"Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response-A Genetic Survey","volume":"10","author":"Tafazoli","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2025.118942_bib121","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7827-12-20","article-title":"Variant-beta luteinizing hormone is not associated with poor ovarian response to controlled ovarian hyperstimulation","volume":"12","author":"Hanevik","year":"2014","journal-title":"Reprod. Biol. Endocrinol. RBE"},{"key":"10.1016\/j.biopha.2025.118942_bib122","series-title":"Hormone Replacement Therapy","author":"Harper-Harrison","year":"2025"},{"key":"10.1016\/j.biopha.2025.118942_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1017468","article-title":"A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions","volume":"13","author":"Emanuel","year":"2022","journal-title":"Front Endocrinol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118942_bib124","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/jpm14090915","article-title":"Ovarian Hyperstimulation Syndrome (OHSS): A Narrative Review and Legal Implications","volume":"14","author":"Gullo","year":"2024","journal-title":"J. Pers. Med"},{"issue":"12","key":"10.1016\/j.biopha.2025.118942_bib125","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.3390\/nu13124562","article-title":"Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks","volume":"13","author":"Raghubeer","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/metabo13020171","article-title":"Regulation of Human Endogenous Metabolites by Drug Transporters and Drug Metabolizing Enzymes: An Analysis of Targeted SNP-Metabolite Associations","volume":"13","author":"Granados","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib127","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jfda.2018.11.005","article-title":"The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders","volume":"27","author":"Wu","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.biopha.2025.118942_bib128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-3163-5-12","article-title":"Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women","volume":"5","author":"Okobia","year":"2006","journal-title":"J. Carcinog."},{"issue":"6","key":"10.1016\/j.biopha.2025.118942_bib129","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/humupd\/dmr034","article-title":"Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?","volume":"17","author":"Altm\u00e4e","year":"2011","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.biopha.2025.118942_bib130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2017.05.004","article-title":"Reevaluating response and failure of medical treatment of endometriosis: a systematic review","volume":"108","author":"Becker","year":"2017","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.biopha.2025.118942_bib131","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5468\/ogs.2018.61.2.192","article-title":"Current medical treatment of uterine fibroids","volume":"61","author":"Sohn","year":"2018","journal-title":"Obstet. Gynecol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:39:10Z","timestamp":1773938350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":131,"alternative-id":["S0753332225011369"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118942","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Descriptive overview of gene variants potentially affecting female infertility treatments: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118942"}}